|

JYP0015 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Guangzhou JOYO Pharma Co., Ltd1

Indications

  • Pancreatic Ductal Adenocarcinoma (PDAC)1
  • Non-small Cell Lung Cancer (NSCLC)1
  • Colorectal Cancer (CRC)1
  • Solid Tumor1
  • Lung Cancer1

Other1 trial

Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.